REGISTERED
on 29 Oct 2024
Last Applicant/ Owned by
Dept. V377, Bldg. AP34-2
North Chicago
IL
60064
Serial Number
98362225 filed on 17th Jan 2024
Registration Number
7552423 registered on 29th Oct 2024
Correspondent Address
Cheryl A. Withycombe
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
ABBVIE
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
First Use Date in General
01st Jan 2013
First Use Date in Commerce
01st Jan 2013
Mark Details
Serial Number
No 98362225
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 29th Oct 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 29th Oct 2024 | REGISTERED-PRINCIPAL REGISTER |
| 13th Aug 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 13th Aug 2024 | PUBLISHED FOR OPPOSITION |
| 24th Jul 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 09th Jul 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 09th Jul 2024 | ASSIGNED TO EXAMINER |
| 15th May 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 17th Jan 2024 | NEW APPLICATION ENTERED |